Tribunal decision favors assessee on impairment loss, sick industrial company status under section 115JB

The Tribunal upheld the CIT(A)'s decision in favor of the assessee regarding the treatment of impairment loss on assets under section 115JB, confirming that the assessee's net worth being negative reduced the profits for computing book profit. The Tribunal also affirmed the CIT(A)'s ruling on the status of the assessee as a sick industrial company under section 115JB, stating that until the net worth equaled or exceeded accumulated losses, relief was applicable. Additionally, the Tribunal dismissed the Revenue's appeal on the taxability of remission of the principal amount due to OTS, following its decision in favor of the assessee on the main issue.

---

---

ISSUES PRESENTED AND CONSIDERED

1. Whether impairment loss charged in the profit and loss account can be disallowed and added back to compute book profits under section 115JB.

2. Whether an undertaking once declared a "sick industrial company" under the Sick Industrial Companies (Special Provisions) Act, 1985 (SICA) loses the protection in section 115JB(2) Explanation 1(vii) of the Income Tax Act by reason of abatement of the BIFR reference consequent to proceedings under the Securitisation and Reconstruction of Financial Assets and Enforcement of Security Interest Act (SARFAESI Act).

3. Whether remission of principal amount under one-time settlement (OTS) is chargeable to tax for computation of book profits under section 115JB, in the circumstances where the company is entitled to claim exemption under Explanation 1(vii) as a sick industrial company.

ISSUE-WISE DETAILED ANALYSIS

Issue 1 - Treatment of impairment loss for computing book profits under section 115JB

Legal framework: Section 115JB computes "book profit" for minimum alternate tax, with adjustments specified by the provision. The statutory text of Explanation 1(vii) to section 115JB(2) exempts profits of a sick industrial company from being subject to tax under that clause until the net worth equals or exceeds accumulated losses. Accounting standards and Companies Act adjustments inform the accounting book profits used as the starting point.

Precedent treatment: The Tribunal's reasoning does not rely on any authority that modifies or departs from the statutory text; no earlier precedent was relied upon or overruled in the decision.

Interpretation and reasoning: The Court treated the computation of book profits as governed by the Act's express adjustments and the specific exemption for sick industrial companies. Where the statutory exemption applies, the Court declined to recharacterise or override accounting treatment (including impairment losses) to frustrate the statutory relief. The decision emphasizes that book profits must be adjusted only in accordance with the Act and the express explanations contained therein.

Ratio vs. Obiter: Ratio - where the statutory exemption under Explanation 1(vii) applies (i.e., company declared sick and net worth less than accumulated losses), profits (including those affected by impairment accounting) fall within the scope of the exemption and are not brought to tax under section 115JB.

Conclusion: The Tribunal upheld the appellate authority's conclusion that the impairment loss, when claimed as part of the accounting/book profit computation by a qualifying sick industrial company, cannot be simply added back or disallowed for the purposes of section 115JB so as to render the company taxable under that section when Explanation 1(vii) applies.

Issue 2 - Effect of BIFR abatement (due to SARFAESI proceedings) on the "sick industrial company" status for section 115JB(2) Explanation 1(vii)

Legal framework: Explanation 1(vii) to section 115JB(2) exempts profits of a company from being taxed as book profits from the assessment year in which it became a sick industrial company under section 17(1) of SICA until the assessment year in which its entire net worth becomes equal to or exceeds accumulated losses. SICA contains provisions for declaration of sickness and for net worth definitions; SARFAESI provides a separate statutory regime for security enforcement. The Income Tax provision contains a "notwithstanding" character by its express statutory scope.

Precedent treatment: No specific judicial precedent was cited by the Tribunal to alter the plain statutory interpretation. The Tribunal followed the statutory text and logic rather than any conflicting administrative action.

Interpretation and reasoning: The Tribunal held that the operation of section 115JB(2) Explanation 1(vii) is governed by its own terms: once a company is declared sick under SICA, the statutory relief continues until the prescribed net worth condition is satisfied. Abatement of BIFR proceedings as a consequence of SARFAESI action does not, by itself, negate the company's status as a sick industrial company for the purpose of section 115JB. The Tribunal reasoned that the Income Tax provision is a self-contained code; where Parliament has provided a specific criterion (declaration under SICA and net worth computation), other legislative processes (such as SARFAESI enforcement) do not operate to nullify the benefit unless the conditions in the Income Tax statute are met. The Tribunal examined the facts (declaration date, abatement, net worth and accumulated losses) and found the net worth remained negative as at the relevant closing date, satisfying the Explanation's condition for continued relief.

Ratio vs. Obiter: Ratio - abatement of BIFR proceedings due to SARFAESI enforcement does not extinguish the exemption under section 115JB(2) Explanation 1(vii); the statutory test is whether the company's net worth has become equal to or exceeds accumulated losses, not whether BIFR proceedings are pending.

Conclusion: The Tribunal upheld the CIT(A)'s finding that abatement of the BIFR reference arising from SARFAESI proceedings did not alter the company's status for the purposes of section 115JB(2) Explanation 1(vii). The exemption continues to apply until the net worth condition in the Explanation is met; consequently, the Assessing Officer's attempt to tax book profits on the ground that BIFR reference had abated was rejected.

Issue 3 - Taxability of remission of principal amount under OTS where Explanation 1(vii) applies

Legal framework: Taxability of remission or settlement amounts depends on whether, for computation of book profits under section 115JB, the relevant amount forms part of profits chargeable to tax. Explanation 1(vii) exempts profits of a sick industrial company until the net worth test is satisfied.

Precedent treatment: The Tribunal did not cite distinct authorities dealing with OTS remission in the context of section 115JB; the decision follows from the principal statutory interpretation reached on Issue 2.

Interpretation and reasoning: The Tribunal treated the question of remission under OTS as a corollary to the determination of whether the company remained a sick industrial company for the purposes of Explanation 1(vii). Having held that the exemption under Explanation 1(vii) applied (net worth still negative), the Tribunal considered grounds challenging denial of OTS treatment to be academic or subsumed by the main finding. Thus, where Explanation 1(vii) applies, profit elements that would otherwise be chargeable (including remission or write-off consequences) do not result in tax under section 115JB.

Ratio vs. Obiter: Ratio - insofar as it follows from the primary holding that Explanation 1(vii) applies, remission of principal under OTS is not chargeable to tax under section 115JB in the relevant assessment year. Observations that the point is "academic" given the main finding are arguably obiter on isolated legal nuances but are binding on the facts.

Conclusion: The Tribunal upheld the CIT(A)'s grant of relief in respect of remission of principal under OTS, concluding that because the company retained its status as a sick industrial company for the purposes of Explanation 1(vii), the remission did not give rise to a charge under section 115JB in the impugned year.

Cross-references and pragmatic holding

1. Issues 1-3 are interlinked: the central legal determination is whether Explanation 1(vii) to section 115JB(2) applies (Issue 2); once it applies, the treatment of impairment losses (Issue 1) and remission under OTS (Issue 3) follows from that statutory exemption.

2. The Tribunal emphasized statutory interpretation: the text and conditions of section 115JB(2) Explanation 1(vii) govern, and other statutory proceedings (SARFAESI) do not by themselves displace that statutory exemption.

---